Schmiegelow K - Search Results

1

Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experience.

Ifversen M, Turkiewicz D, Marquart HV, Winiarski J, Buechner J, Mellgren K, Arvidson J, Rascon J, Körgvee LT, Madsen HO, Abrahamsson J, Lund B, Jonsson OG, Heilmann C, Heyman M, Schmiegelow K, Vettenranta K. Ifversen M, et al. Among authors: schmiegelow k. Br J Haematol. 2019 Mar;184(6):982-993. doi: 10.1111/bjh.15761. Epub 2019 Jan 24. Br J Haematol. 2019. PMID: 30680711 Free article.

2

Maintenance chemotherapy for childhood acute lymphoblastic leukemia: should dosage be guided by white blood cell counts?

Schmiegelow K, Pulczynska MK. Schmiegelow K, et al. Am J Pediatr Hematol Oncol. 1990 Winter;12(4):462-7. doi: 10.1097/00043426-199024000-00010. Am J Pediatr Hematol Oncol. 1990. PMID: 2285127

3

White-cell counts in childhood acute lymphoblastic leukemia.

Schmiegelow K, Pulczynska MK. Schmiegelow K, et al. Eur J Haematol. 1990 Jan;44(1):72-4. doi: 10.1111/j.1600-0609.1990.tb00351.x. Eur J Haematol. 1990. PMID: 2307222 No abstract available.

4

Prognostic significance of hepatotoxicity during maintenance chemotherapy for childhood acute lymphoblastic leukaemia.

Schmiegelow K, Pulczynska M. Schmiegelow K, et al. Br J Cancer. 1990 May;61(5):767-72. doi: 10.1038/bjc.1990.172. Br J Cancer. 1990. PMID: 2337515 Free PMC article.

5

White cell count during maintenance chemotherapy for standard-risk childhood acute lymphoblastic leukemia: relation to relapse rate.

Schmiegelow K, Pulczynska MK, Seip M. Schmiegelow K, et al. Pediatr Hematol Oncol. 1988;5(4):259-67. doi: 10.3109/08880018809037365. Pediatr Hematol Oncol. 1988. PMID: 3152971

6

Childhood non-Hodgkin's lymphoma in the five Nordic countries. A five-year population-based study from the Nordic Society of Pediatric Hematology and Oncology.

Márky I, Schmiegelow K, Perkkiö M, Jónsson OG, Storm-Mathiesen I, Gustafsson G, Kreuger A, Langmark F. Márky I, et al. Among authors: schmiegelow k. J Pediatr Hematol Oncol. 1995 May;17(2):163-6. doi: 10.1097/00043426-199505000-00011. J Pediatr Hematol Oncol. 1995. PMID: 7749767

7

[Molecular biology diagnosis and monitoring in acute lymphoblastic leukemia and non-Hodgkin-lymphoma].

Svejgaard A, Madsen HO, Nyvold C, Ryder LP, Schmiegelow K. Svejgaard A, et al. Among authors: schmiegelow k. Ugeskr Laeger. 1996 Dec 2;158(49):7101-2. Ugeskr Laeger. 1996. PMID: 8999621 Danish. No abstract available.

8

Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia. Nordic Society for Pediatric Hematology and Oncology (NOPHO).

Schmiegelow K, Glomstein A, Kristinsson J, Salmi T, Schrøder H, Björk O. Schmiegelow K, et al. J Pediatr Hematol Oncol. 1997 Mar-Apr;19(2):102-9. doi: 10.1097/00043426-199703000-00002. J Pediatr Hematol Oncol. 1997. PMID: 9149738

9

Hoffmann T, Heilmann C, Madsen HO, Vindeløv L, Schmiegelow K. Hoffmann T, et al. Among authors: schmiegelow k. Bone Marrow Transplant. 1998 Sep;22(6):603-4. doi: 10.1038/sj.bmt.1701389. Bone Marrow Transplant. 1998. PMID: 9758353

10

Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia.

Nyvold C, Madsen HO, Ryder LP, Seyfarth J, Engel CA, Svejgaard A, Wesenberg F, Schmiegelow K. Nyvold C, et al. Among authors: schmiegelow k. J Immunol Methods. 2000 Jan 13;233(1-2):107-18. doi: 10.1016/s0022-1759(99)00113-1. J Immunol Methods. 2000. PMID: 10648861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

537 results

Search Page